Geron Corporation

Geron Corporation - PE Ratioverified

0IV3.L

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company's product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia; IMerge which is in Phase 3 clinical trial for the treatment of lower-risk myelodysplastic syndromes; IMpactMF that is in Phase 3 for the treatment of relapsed/refractory myelofibrosis; Impress which is in Phase 2 clinical trial to treat higher risk myelodysplastic syndromes and acute myeloid leukemia (AML); IMproveMF which is in Phase 1 clinical trial for the treatm...[Read more]

Industry

Biotechnology

IPO Date

2018-01-29

Stock Exchange

LSE

Ticker

0IV3.L

The PE Ratio as of July 2026 (TTM) for Geron Corporation (0IV3.L) is -12.61

According to Geron Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -12.61. This represents a change of -50.93% compared to the average of -25.70 of the last 4 quarters.

Geron Corporation (0IV3.L) Historical PE Ratio (quarterly & annually)

How has 0IV3.L PE Ratio performed in the past?

The mean historical PE Ratio of Geron Corporation over the last ten years is -7.71. The current -12.61 PE Ratio has changed 16.26% with respect to the historical average. Over the past ten years (40 quarters), 0IV3.L's PE Ratio was at its highest in in the December 2019 quarter at -2.27. The PE Ratio was at its lowest in in the March 2026 quarter at -68.98.

Quarterly (TTM)
Annual

Average

-7.71

Median

-6.63

Minimum

-13.11

Maximum

-3.30

Geron Corporation (0IV3.L) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Geron Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 98.84%

Maximum Annual PE Ratio = -3.30

Minimum Annual Increase = -100.07%

Minimum Annual PE Ratio = -13.11

Quarterly (TTM)
Annual
YearPE RatioChange
2025-10.15-22.56%
2024-13.1198.84%
2023-6.590.81%
2022-6.5498.36%
2021-3.30-41.93%
2020-5.6837.79%
2019-4.12-38.18%
2018-6.67-33.33%
2017-10.00-8.21%
2016-10.89-100.07%

Geron Corporation (0IV3.L) Average PE Ratio

How has 0IV3.L PE Ratio performed in the past?

The current PE Ratio of Geron Corporation (0IV3.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-9.95

5-year avg

-7.94

10-year avg

-7.71

Geron Corporation (0IV3.L) PE Ratio vs. Peers

How is 0IV3.L’s PE Ratio compared to its peers?

Geron Corporation’s PE Ratio is less than Iovance Biotherapeutics, Inc. (-5.07), less than Anavex Life Sciences Corp. (-5.05), less than Myriad Genetics, Inc. (-1.44), greater than Esperion Therapeutics, Inc. (-131.40), greater than Axogen, Inc. (-62.92), less than Verastem, Inc. (-2.31), greater than Emergent BioSolutions Inc. (-45.24), less than Nektar Therapeutics (-7.96), less than OPKO Health, Inc. (-4.32), less than Editas Medicine, Inc. (-2.35),

Build a custom stock screener for Geron Corporation (0IV3.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Geron Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Geron Corporation (0IV3.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Geron Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Geron Corporation's PE Ratio?

How is the PE Ratio calculated for Geron Corporation (0IV3.L)?

What is the highest PE Ratio for Geron Corporation (0IV3.L)?

What is the 3-year average PE Ratio for Geron Corporation (0IV3.L)?

What is the 5-year average PE Ratio for Geron Corporation (0IV3.L)?

How does the current PE Ratio for Geron Corporation (0IV3.L) compare to its historical average?